Items where Author is "Mahdevar, M."

Article

(2026) Candidate Prognostic LncRNAs Including C2orf49-DT, CAPN10-DT, LOC105371795 as Potential Biomarkers for Colorectal Cancer. Biochemical genetics. pp. 5526-5540. ISSN 1573-4927 (Electronic) 0006-2928 (Linking)

(2026) Elevated Expression of LINC02257 and LINC00659 in Breast Cancer is Associated with Poor Survival and Immune Cell Infiltration. Current Genetic Medicine Reports. p. 13.

(2026) LENG8-AS1: A Prognostic Biomarker in Colorectal Cancer-Differential Expression and Clinical Implications. Indian journal of clinical biochemistry : IJCB. pp. 105-112. ISSN 0970-1915 (Print) 0974-0422 (Electronic) 0970-1915 (Linking)

(2026) Novel p53-related lncRNAs as immune-associated biomarkers in colorectal cancer. Egyptian Journal of Medical Human Genetics. p. 16. ISSN 1110-8630

(2026) Pseudogene expression as predictors of survival in colorectal cancer: Focus on CCT6P1 and SMPD4BP. Human Gene. p. 9. ISSN 2773-0441

(2026) Silencing TMEM105 suppresses gastric cancer cell growth and migration via proliferation-associated pathways. Bmc Cancer. ISSN 14712407 (ISSN)

(2026) ZnO@Carvacrol nanoparticles effectively suppress biofilm and quorum-sensing mechanisms in MDR Acinetobacter baumannii. Bmc Microbiology. p. 16. ISSN 1471-2180

(2025) Alterations in NFAT5 and ATP6V1E1 expression as potential diagnostic biomarkers in blood and brain for Alzheimer's disease: A study of gene overlap. Brain research. p. 149599. ISSN 1872-6240 (Electronic) 0006-8993 (Linking)

(2025) Analysing glycolysis-related genes reveals the prognostic and diagnostic relevance of IER3 and AGRN in colorectal cancer. Genes & Genomics. p. 12. ISSN 1976-9571

(2025) Arginine-proline metabolism as a prognostic and therapeutic target in triple-negative breast cancer: an in silico and ex vivo investigation. Indian Journal of Clinical Biochemistry. p. 10. ISSN 0970-1915

(2025) Exploring non-coding RNA expression profiles of AKR1B10P1, RP11-465B22.3, WASH8P, and NPM1P25 as a predictive model for hepatocellular carcinoma patient survival. Discover Oncology. p. 13.

(2025) Functionalized 3D-printed scaffolds for enhanced osteogenesis and guided bone regeneration. Journal of Materials Chemistry B. pp. 6493-6507. ISSN 2050-750X

(2025) Increased Expression of RCN1P2, TPM3P9, and HSP90AB3P as Non-Coding RNA in Gastric Cancer Linked to Proliferative, Inflammatory and Metastatic Pathways through a Competing Endogenous RNAs Network. Iranian Journal of Public Health. pp. 1074-1086. ISSN 2251-6085

(2025) Insights into the E2F target genes in breast cancer: associations of pathway genes with prognosis and immune cell filtration based on in silico and ex vivo analyses. Cancer Cell International. p. 14.

(2025) Silencing TMEM105 suppresses gastric cancer cell growth and migration via proliferation-associated pathways. Bmc Cancer. p. 11.

(2025) Therapeutic Potential of PLK1, KIF4A, CDCA5, UBE2C, CDT1, SKA3, AURKB, and PTTG1 Genes in Triple-Negative Breast Cancer: Correlating Their Expression with Sensitivity to GSK 461364 and IKK 16 Drugs. Biochemical genetics. pp. 3845-3862. ISSN 1573-4927 (Electronic) 0006-2928 (Linking)

(2024) Construction of a cell cycle-specific lncRNA-miRNA-mRNA network reveals novel key lncRNAs in colorectal cancer. Biomarkers. pp. 565-576. ISSN 1354-750X

(2024) Exploring the role of interleukin 11 in cancer progression, patient survival, and therapeutic insights. Molecular Biology Reports. p. 9. ISSN 0301-4851

(2024) Identification of genes related to ribosomal proteins in colorectal cancer: exploring their potential as biomarkers, prognostic indicators, and therapeutic targets. Molecular Biology Reports. p. 16. ISSN 0301-4851

(2024) LENG8-AS1: A Prognostic Biomarker in Colorectal Cancer-Differential Expression and Clinical Implications. Indian Journal of Clinical Biochemistry. p. 8. ISSN 0970-1915

(2024) TBX15 and SDHB expression changes in colorectal cancer serve as potential prognostic biomarkers. Experimental and Molecular Pathology. p. 11. ISSN 0014-4800

(2024) Therapeutic Potential of PLK1, KIF4A, CDCA5, UBE2C, CDT1, SKA3, AURKB, and PTTG1 Genes in Triple-Negative Breast Cancer: Correlating Their Expression with Sensitivity to GSK 461364 and IKK 16 Drugs. Biochemical Genetics. p. 18. ISSN 0006-2928

(2022) Identification of genes with high heterogeneity of expression as a predictor of different prognosis and therapeutic responses in colorectal cancer: a challenge and a strategy. Cancer Cell International. p. 12.

(2021) Steroid receptor RNA activator gene footprint in the progression and drug resistance of colorectal cancer through oxidative phosphorylation pathway. LIFE SCIENCES. ISSN 0024-3205 1879-0631 J9 - LIFE SCI